Before the sun has even risen on the first day of J.P. Morgan’s 2023 annual healthcare conference, two Eli Lilly execs already have their plates full, dubbing 2023 the year of new modalities and new medicines for the Big Pharma.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,